Wadih Arap

Q: What Schools Are Affiliated With Wadih Arap

Wadih Arap is affiliated with the following schools: University of Amsterdam, George Washington University, MD Anderson Cancer Center, Imperial College London, University of Melbourne, Massachusetts Institute of Technology, University of New Mexico, University of California, San Francisco, University of São Paulo, University of Vienna

Wadih Arap's AcademicInfluence.com Rankings

Wadih Arap

Philosophy

#8342

World Rank

#11699

Historical Rank

Logic

#5374

World Rank

#6768

Historical Rank

philosophy Degrees

Wadih Arap

Biology

#11276

World Rank

#14661

Historical Rank

Molecular Biology

#1726

World Rank

#1755

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Wadih Arap's Degrees

Doctorate Medicine University of São Paulo
PhD Molecular Biology University of São Paulo

Why Is Wadih Arap Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wadih Arap's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. (1998) (2019)
Anti-cancer activity of targeted pro-apoptotic peptides (1999) (872)
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. (2000) (855)
Quality of life and satisfaction with outcome among prostate-cancer survivors. (2008) (841)
A Population of Multipotent CD34-Positive Adipose Stromal Cells Share Pericyte and Mesenchymal Surface Markers, Reside in a Periendothelial Location, and Stabilize Endothelial Networks (2008) (823)
Steps toward mapping the human vasculature by phage display (2002) (580)
Tumor targeting with a selective gelatinase inhibitor (1999) (578)
Reversal of obesity by targeted ablation of adipose tissue (2004) (556)
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? (2008) (551)
Three-dimensional tissue culture based on magnetic cell levitation. (2010) (524)
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. (1998) (468)
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. (2004) (385)
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors (2003) (377)
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. (1996) (370)
Fingerprinting the circulating repertoire of antibodies from cancer patients (2003) (334)
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer (2013) (318)
Genetic basis for in vivo daptomycin resistance in enterococci. (2011) (312)
Targeting the prostate for destruction through a vascular address (2002) (298)
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. (2009) (293)
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. (2001) (293)
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. (2002) (272)
Biopanning and rapid analysis of selective interactive ligands (2001) (258)
Display technologies: Application for the discovery of drug and gene delivery agents (2006) (257)
A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging (2006) (240)
Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids. (2001) (235)
Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents (2006) (235)
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3 (2015) (217)
Optical Systems for in Vivo Molecular Imaging of Cancer (2003) (211)
A Previously Unrecognized Protein-Protein Interaction between TWEAK and CD163: Potential Biological Implications1 (2007) (206)
SPARC Regulates Extracellular Matrix Organization through Its Modulation of Integrin-linked Kinase Activity* (2005) (201)
Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. (1997) (200)
Probing the structural and molecular diversity of tumor vasculature. (2002) (197)
In vivo phage display and vascular heterogeneity: implications for targeted medicine. (2002) (192)
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. (2009) (185)
State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. (2006) (183)
The neovasculature homing motif NGR: more than meets the eye. (2008) (176)
NG2 proteoglycan-binding peptides target tumor neovasculature. (1999) (174)
Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate–Induced Cardiotoxicity (2013) (172)
Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC1 (2006) (170)
A physical sciences network characterization of non-tumorigenic and metastatic cells (2013) (157)
Identification of receptor ligands with phage display peptide libraries. (1999) (147)
Aminopeptidase A is a functional target in angiogenic blood vessels. (2004) (145)
Next-Generation Phage Display: Integrating and Comparing Available Molecular Tools to Enable Cost-Effective High-Throughput Analysis (2009) (145)
Vascular Targeting: Recent Advances and Therapeutic Perspectives (2006) (138)
Enhanced relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticles. (2011) (137)
Ligand-targeted theranostic nanomedicines against cancer. (2016) (133)
Synchronous selection of homing peptides for multiple tissues by in vivo phage display (2006) (133)
Combinatorial Screenings in Patients (2004) (131)
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. (2011) (131)
Molecular addresses in blood vessels as targets for therapy. (2001) (130)
Loss of P16INK4 expression is frequent in high grade gliomas. (1995) (129)
Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. (1995) (126)
Impaired angiogenesis in aminopeptidase N-null mice (2007) (122)
Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the Mouse*S⃞ (2008) (120)
Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature (2009) (113)
Targeted Drug Delivery and Penetration Into Solid Tumors (2012) (112)
Chemotherapy targeted to tumor vasculature. (1998) (107)
Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment (2012) (104)
Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice. (2012) (103)
Targeting neuropilin-1 in human leukemia and lymphoma. (2011) (101)
Discovery of a functional protein complex of netrin-4, laminin γ1 chain, and integrin α6β1 in mouse neural stem cells (2009) (94)
Design and construction of targeted AAVP vectors for mammalian cell transduction (2007) (93)
Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection. (2005) (91)
Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis? (2008) (89)
Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide. (2008) (86)
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. (2010) (83)
A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys (2011) (82)
GRP78 signaling hub a receptor for targeted tumor therapy. (2010) (81)
Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. (2006) (80)
Ethics guidelines for research with the recently dead (2005) (77)
IFATS Collection: Combinatorial Peptides Identify α5β1 Integrin as a Receptor for the Matricellular Protein SPARC on Adipose Stromal Cells (2008) (74)
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. (2008) (73)
The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. (2009) (73)
Tumor vasculature‐targeted delivery of tumor necrosis factor‐α * (2009) (71)
Design and validation of a bifunctional ligand display system for receptor targeting. (2004) (70)
In vivo detection of gold-imidazole self-assembly complexes: NIR-SERS signal reporters. (2006) (69)
A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging (2008) (68)
Peptides Targeting Caspase Inhibitors* (2003) (68)
Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU (2007) (67)
Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients (2011) (66)
Role of leukemia cell invadosome in extramedullary infiltration. (2009) (66)
Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78 (2013) (65)
From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathway (2010) (65)
Luminescent silica nanoparticles for cancer diagnosis. (2013) (64)
Nna1 Mediates Purkinje Cell Dendritic Development via Lysyl Oxidase Propeptide and NF-κB Signaling (2010) (62)
An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration (2001) (60)
An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients (2004) (60)
Hybridoma-free generation of monoclonal antibodies (2003) (59)
Peptidase Substrates via Global Peptide Profiling (2008) (57)
Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries. (2016) (57)
Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells* (2008) (56)
From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway (2010) (55)
An integrated approach for the rational design of nanovectors for biomedical imaging and therapy. (2010) (54)
Role of the gp85/Trans-Sialidases in Trypanosoma cruzi Tissue Tropism: Preferential Binding of a Conserved Peptide Motif to the Vasculature In Vivo (2010) (53)
A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage–mediated, vascular-targeted suicide gene transfer (2009) (52)
αvβ5 Integrin-Dependent Programmed Cell Death Triggered by a Peptide Mimic of Annexin V (2003) (52)
Mapping tumor vascular diversity by screening phage display libraries. (2003) (50)
Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic (2013) (49)
Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma (2005) (47)
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors (2015) (47)
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes (2020) (47)
MicroRNAs and Ultraconserved Genes as Diagnostic Markers and Therapeutic Targets in Cancer and Cardiovascular Diseases (2010) (45)
Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors. (2005) (45)
Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. (2005) (44)
A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6 (2012) (44)
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release (2016) (44)
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer (2016) (44)
Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells (2012) (43)
Bottom-Up Assembly of Hydrogels from Bacteriophage and Au Nanoparticles: The Effect of Cis- and Trans-Acting Factors (2008) (43)
Teratogenicity induced by targeting a placental immunoglobulin transporter (2002) (43)
Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study (2015) (43)
A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies (2017) (43)
The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease (2015) (42)
Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems. (2008) (42)
Modulation of the immune response by systemic targeting of antigens to lymph nodes. (2001) (42)
Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. (2016) (41)
Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer* (2015) (40)
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer (2015) (40)
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings. (2013) (40)
Functional analysis of wild-type and malignant glioma derived CDKN2Aβ alleles: Evidence for an RB-independent growth suppressive pathway (1997) (40)
An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment (2009) (39)
Tissue plasminogen activator regulates Purkinje neuron development and survival (2013) (38)
Techniques to decipher molecular diversity by phage display. (2007) (38)
A Ligand Peptide Motif Selected from a Cancer Patient Is a Receptor-Interacting Site within Human Interleukin-11 (2008) (37)
Revisiting ethical guidelines for research with terminal wean and brain-dead participants. (2003) (36)
B‐cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia (2011) (36)
Point mutations can inactivate in vitro and in vivo activities of p16INK4a/CDKN2A in human glioma (1997) (36)
AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas (2016) (36)
A multifunctional streptococcal collagen-mimetic protein coating prevents bacterial adhesion and promotes osteoid formation on titanium. (2014) (35)
Combinatorial ligand-directed lung targeting. (2009) (35)
CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis (2013) (34)
Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V. (2003) (34)
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors (2016) (34)
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer (2016) (34)
Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995–2012 (2015) (34)
Aminopeptidase N inhibitors and SARS (2003) (34)
Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review (2019) (33)
Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting (2017) (33)
Superfibronectin, a Multimeric Form of Fibronectin, Increases HIV Infection of Primary CD4+ T Lymphocytes1 (2000) (33)
Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels. (2006) (31)
Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity (2012) (31)
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy (2020) (31)
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch (2015) (31)
Processing of the Matricellular Protein Hevin in Mouse Brain Is Dependent on ADAMTS4* (2009) (31)
Integrin-binding peptides derived from phage display libraries. (1999) (31)
Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone. (2017) (29)
Treatment of hypoxia‐induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease (2007) (29)
A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation (2008) (28)
Vascular targeting and antigen presentation (2001) (28)
Molecular targets on blood vessels for cancer therapies in clinical trials. (2007) (28)
Exploring vascular heterogeneity for gene therapy targeting (2000) (28)
Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides. (2008) (27)
Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging. (2010) (27)
Targeting mammalian organelles with internalizing phage (iPhage) libraries (2013) (27)
Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands. (2003) (26)
Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer (2019) (26)
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes (2016) (25)
An Antimicrobial Peptidomimetic Induces Mucorales Cell Death through Mitochondria-Mediated Apoptosis (2013) (25)
Inhibitory Peptides of the Sulfotransferase Domain of the Heparan Sulfate Enzyme, N-Deacetylase-N-sulfotransferase-1 (2010) (25)
Profiling the molecular diversity of blood vessels. (2002) (24)
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates (2017) (22)
Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions. (2018) (22)
TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection. (2019) (22)
Targeting cancer-specific synthetic lethality in double-strand DNA break repair (2009) (22)
BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation (2017) (21)
Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens. (2017) (21)
Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain (2021) (21)
Reactive antibodies against bacillus Calmette‐Guerin heat‐shock protein‐65 potentially predict the outcome of immunotherapy for high‐grade transitional cell carcinoma of the bladder (2010) (21)
Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model (2020) (20)
An Artificially Designed Pore-forming Protein with Anti-tumor Effects* (2003) (19)
Combinatorial targeting and nanotechnology applications (2010) (19)
Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential. (2013) (19)
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies (2019) (19)
The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury. (2020) (19)
The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients. (2015) (18)
Fatty acid mobilization from adipose tissue is mediated by CD36 posttranslational modifications and intracellular trafficking (2021) (18)
Phage display technology for stem cell delivery and systemic therapy. (2010) (18)
Poly (A)+ Transcriptome Assessment of ERBB2-Induced Alterations in Breast Cell Lines (2011) (17)
Engineered embryonic endothelial progenitor cells as therapeutic Trojan horses. (2004) (17)
Structural models of SARS-CoV-2 Omicron variant in complex with ACE2 receptor or antibodies suggest altered binding interfaces (2021) (16)
The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1. (2007) (16)
Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis (2015) (16)
The human vascular mapping project. Selection and utilization of molecules for tumor endothelial targeting. (2001) (15)
Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates. (2020) (15)
Predicting breast cancer response to neoadjuvant chemotherapy based on tumor vascular features in needle biopsies. (2019) (15)
Vessel maneuvers: Zinc fingers promote angiogenesis (2002) (14)
Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model (2020) (14)
Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor (2017) (14)
Ceramide launches an acute anti‐adhesion pro‐migration cell signaling program in response to chemotherapy (2020) (14)
Phenotypic diversity of the lung vasculature in experimental models of metastases. (2005) (13)
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity. (2016) (12)
Development of a Ligand-Directed Approach To Study the Pathogenesis of Invasive Aspergillosis (2005) (12)
Does the RAAS play a role in loss of taste and smell during COVID-19 infections? (2020) (12)
Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial (2019) (12)
Targeting synthetic lethality in DNA damage repair pathways as an anti-cancer strategy. (2010) (12)
Targeting Synthetic Lethality in DNA Damage Repair Pathways as an Anti-Cancer Strategy (2010) (11)
Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications. (2018) (11)
A ligand motif enables differential vascular targeting of endothelial junctions between brain and retina (2019) (10)
Translation of vascular diversity into targeted therapeutics. (2002) (10)
Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses (2017) (9)
Identification of Novel Immunoregulatory Molecules in Human Thymic Regulatory CD4+CD25+ T Cells by Phage Display (2011) (8)
Tumor and serum beta-2-microglobulin expression in women with breast cancer. (1989) (8)
Brain endothelial cell‐targeted gene therapy of neurovascular disorders (2016) (8)
Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens (2015) (8)
Combinatorial vascular targeting in translational medicine (2010) (8)
Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer (2021) (8)
Bayesian mixture models for complex high dimensional count data in phage display experiments (2007) (7)
Drug design strategies for the treatment of prostate cancer (2015) (7)
Ligand-directed Cancer Gene Therapy to Angiogenic Vasculature (2009) (7)
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin (2009) (7)
Predicting Proteome-Scale Protein Structure with Artificial Intelligence. (2021) (7)
Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer (2021) (7)
Semiparametric Bayesian Inference for Phage Display Data (2013) (7)
Model of unidirectional transluminal gene transfer. (2004) (6)
CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis (2016) (6)
Targeting the extracellular signature of metastatic colorectal cancers (2009) (6)
Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain (2021) (6)
A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases (2020) (6)
MLH1-rheMac hereditary nonpolyposis colorectal cancer syndrome in rhesus macaques (2018) (6)
Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction (2020) (5)
NG 2 Proteoglycan-binding Peptides Target Tumor Neovasculature 1 (1999) (5)
Discovery of DNA repair inhibitors by combinatorial library profiling. (2011) (5)
Cracking the code for compartment-specific dual functionality proteins in cancer: The case for CRKL (2010) (5)
Amphibian regeneration and mammalian cancer: Similarities and contrasts from an evolutionary biology perspective (2021) (4)
Meeting report: innovations in prostate cancer research. (2008) (4)
TLR 9 / MyD 88 / TRIF signaling activates host immune inhibitory CD 200 in Leishmania infection (2019) (4)
Apropos of Universal Epitope Discovery for COVID-19 Vaccines: A Framework for Targeted Phage Display-Based Delivery and Integration of New Evaluation Tools (2021) (4)
Is the worst of the COVID-19 global pandemic yet to come? Application of financial mathematics as candidate predictive tools (2021) (4)
An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications (2017) (4)
Is annexin 7 a tumor suppressor gene in prostate cancer? (2001) (4)
Mapping human vascular heterogeneity by in vivo phage display (2003) (4)
Ligand-directed profiling: applications to target drug discovery in cancer (2009) (4)
Bone marrow-derived CD13+ cells sustain tumor progression (2014) (4)
A refined genome phage display methodology delineates the human antibody response in patients with Chagas disease (2021) (4)
Linear mRNA amplification approach for RNAseq from limited amount of RNA. (2015) (4)
Eph receptors as cancer targets for antibody-based therapy. (2020) (3)
Targeting the extracellular signature of metastatic colorectal cancers. (2009) (3)
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial (2022) (3)
Translation of Vascular Proteomics into Individualized Therapeutics (2003) (3)
Prostate Cancer Progression and the Epigenome. (2020) (3)
Characterization of the anaplastic prostate carcinomas: A prospective two-stage phase II trial of frontline carboplatin and docetaxel (CD) and salvage etoposide and cisplatin (EP). (2011) (3)
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling (2021) (3)
Design, development, and validation of a high‐throughput drug‐screening assay for targeting of human leukemia (2014) (3)
Ceramide-mediated apoptosis following ionizing radiation in human prostate cancer cells: PKCα joins the fray (2009) (3)
Expression of integrin transcripts in human cancer cells. (1999) (2)
Protein Discovery Technologies (2009) (2)
Ligand-directed therapy and molecular imaging based on in vivo phage display technology (2015) (2)
Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats (2022) (2)
Immunoblotting of integrins. (1999) (2)
Ligand‐Directed Profiling of Organelles with Internalizing Phage Libraries (2015) (2)
On the synergistic effects of ligand-mediated and phage-intrinsic properties during in vivo selection. (2010) (2)
Correction: Poly (A)+ Transcriptome Assessment of ERBB2-Induced Alterations in Breast Cell Lines (2011) (2)
Repurposing Ferumoxytol as a Breast Cancer-Associated Macrophage Tracer with Five-Dimensional Quantitative [Fe]MRI of SPION Dynamics (2021) (1)
Targeting interleukin-11 receptor in leukemia and lymphoma: A functional ligand-directed study and hematopathology analysis of patient-derived specimens (2015) (1)
Replacement of the pl 6 / CDKN 2 Gene Suppresses Human Glioma Cell Growth 1 (2006) (1)
Neutrophil-Secreted Proteinase 3 Mediates Metastasis of Prostate Cancer Cells Expressing RAGE to the Bone Marrow (2016) (1)
Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22 (2023) (1)
PRUNE2 and PCA3 expression in paired non-malignant and tumor specimens from radical prostatectomy patients with gleason score 7 prostate cancer. (2017) (1)
Mathematical modeling of cancer immunotherapy for personalized clinical translation (2022) (1)
PCA3 upregulation in prostate cancer: Analysis in a cohort of 497 subjects from TCGA. (2017) (1)
The epigenetic reader PHF21B modulates murine social memory and synaptic plasticity–related genes (2022) (1)
Protocol for design, construction, and selection of genome phage (gPhage) display libraries (2021) (1)
Abstract 5368: A phase II study of ipilumimab plus androgen deprivation therapy in castration-sensitive prostate carcinoma (2012) (1)
Advances in Brief Combinatorial Screenings in Patients : The Interleukin-11 Receptor as a Candidate Target in the Progression of Human Prostate Cancer (2004) (1)
Antibody reproducibility challenges: the solution lies in the sequence (2016) (1)
Humans Molecule / MUC 18-Dependent Interaction : Evidence from Mice Metastasis through a Melanoma Cell Adhesion A Subset of Host B Lymphocytes Controls Melanoma (2008) (1)
Response to Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys” (2012) (1)
Abstract 3543: Ligand-directed and transcription-based molecular imaging and treatment of cancer (2015) (1)
An antivascular vaccine to boost self-immunity and strike the tumor (2017) (1)
Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection (2022) (1)
Cancer Metastasis: Stromal-Derived Factors That Dictate Organ-Specific Metastasis (2011) (1)
Do Pandemics Obey the Elliott Wave Principle of Financial Markets? (2021) (1)
Vascular Targeting of Brain Tumors – Bridging the Gap with Phage Display (2009) (1)
By phage display identified target peptides found in human and mouse (2001) (0)
Tumor Targeting Peptides for Cytotoxic, Chemotherapy Delivery (1999) (0)
Targeting the extracellular signature of metastatic colon cancers (2008) (0)
Abstract 1625: Discovery of a breast cancer targeting peptide with anti-tumor activity (2010) (0)
A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies (2017) (0)
T Lymphocytes + Primary CD4 Fibronectin, Increases HIV Infection of Superfibronectin, a Multimeric Form of (2000) (0)
Abstract 3911: Bacteriophage associated silicon particles (BASP) for targeting pancreatic neuroendocrine tumors (2016) (0)
Genomic DNA Gliomas Identified Using Two-dimensional Separation of Cyclin-dependent Kinase 6 ( CDK 6 ) Amplification in Human Updated (2006) (0)
Integrated metabolic and genetic analysis reveals distinct features of primary differentiated thyroid cancer and its metastatic potential in humans (2023) (0)
Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting (2017) (0)
Thanks to Reviewers (2014) (0)
Comprar Protein Discovery Technologies | Renata Pasqualini | 9780824754686 | Informa Healthcare (2007) (0)
Primary CD4+ T Lymphocytes Fibronectin, Increases HIV Infection of Superfibronectin, a Multimeric Form of (2013) (0)
Zinc-finger transcription factors can be engineered to target specific genes. Now this approach is applied successfully to a clinically relevant setting in mice—promotion of angiogenesis. (pages 1427-1432) (2002) (0)
An extra-cellular protein signature of metastatic colon cancer (2007) (0)
Abstract 5620: Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings. (2013) (0)
Abstract P3-10-09: Peptide-based molecular targeting of inflammatory breast cancer. (2012) (0)
through a specific interaction with gp120 viral envelope protein Cell surface-associated Tat modulates HIV-1 infection and spreading (2011) (0)
Vascular Addresses Revealed by Combinatorial Screenings in Vivo (2006) (0)
Preclinical development of an interleukin-11 receptor-targeted pro-apoptotic peptide against advanced prostate cancer. (2004) (0)
PP102 Monitoring BCG immunotherapy for high risk urothelial cancer of the urinary bladder – a novel biomarker (2009) (0)
Diagnostic and therapeutic applications of bacteriophage and adeno-associated virus technologies in pulmonary emphysema (2006) (0)
The use of proteomics to map phenotypic heterogeneity of the endothelium (2005) (0)
Abstract 2903: Therapeutic targeting of leukemia and lymphoma with a neuropilin-1 binding pro-apoptotic peptide (2012) (0)
Modulation of the Immune Response by Systemic Targeting of Antigens to Lymph Nodes 1 (2001) (0)
606: Identification of AN43, a Tumor Associated Antigen Found in Bladder Cancer (2005) (0)
Targeting IL 11 Receptor in Leukemia and Lymphoma : A Functional Ligand-Directed Study andHematopathologyAnalysisofPatient-Derived Specimens (2015) (0)
Correction: Poly (A) Transcriptome Assessment of -Induced Alterations in Breast Cell Lines. (2011) (0)
B-Cell Receptor Profiling Suggests a Limited Number of Antigens Involved in the Pathogenesis of Chronic Lymphocytic Leukemia. (2008) (0)
Speaker Abstracts (2000) (0)
Methods Leukemia and lymphoma cell lines The human cell lines (2011) (0)
A phage display perspective (2007) (0)
Evaluation of PRUNE2 and PCA3 expression as metastasis predictors in Gleason 7 prostate cancer. (2017) (0)
Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells (2022) (0)
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts (2022) (0)
Reply to bladder cancer and BCG response prediction: What we must know? (2011) (0)
Decoding Tumor Zip Codes to Design Targeted Drugs to Treat Leukemia, Lymphoma, and Solid Tumors (2016) (0)
Abstract 15009: A Novel Role of Coronary Pericytes in Sunitinib Induced Cardiotoxicity (2012) (0)
TU‐C‐BRB‐10: Nanoscaffold‐Enhanced Proton Therapy (2012) (0)
Tissue-specific vascular endothelial signals and vector targeting (2009) (0)
Abstract 4322: Ligand-directed therapy and molecular imaging in a mouse model of androgen-independent osteogenic prostate cancer (2010) (0)
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies (2019) (0)
Abstract 3625: Novel phage-display derived peptides for tumor- and vasculature-targeted therapies in neuroblastoma (2011) (0)
Combination of peptides-targeted liposomal chemotherapy against neuroblastoma (2009) (0)
Abstract LB-006: Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer (2015) (0)
Abstract 582: Targeting the blood-brain barrier with a non-canonical iron-mimicry mechanism: A translational approach for the detection and treatment of human brain tumors (2010) (0)
An Anti-Ubiquitin Antibody Response in Transitional Cell Carcinoma of the Urinary Bladder (2015) (0)
DISCOVERY OF NOVEL LIGAND/RECEPTOR PAIRS TARGETING ATHEROSCLEROTIC TISSUE IN THE WATANABE HEREDITARY HYPERLIPIDEMIC (WHHL) RABBIT (2011) (0)
Author response: Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer (2021) (0)
254 INVITED Tumour vascular diversity and its translation into targeted therapeutics (2006) (0)
Combinatorial Mapping of Vascular Zip Codes by In Vivo Phage Display (2009) (0)
Inhibition of mammary tumor growth and metastasis by targeting cell surface associated GRP78 (2009) (0)
Nanovectors targeting cell surface receptors (2012) (0)
Mathematical modeling identifies optimal dosing schedules for COVID-19 vaccines to minimize breakthrough infections (2022) (0)
of SPARC Clearance Macrophages: Stabilin-1-Mediated Novel Function of Alternatively Activated (2006) (0)
Endothelial Apoptosis Promotes Lung Tissue Remodeling And Emphysema Via Matrix Metalloproteinase 9 (2012) (0)
TU-A-108-11: Nanoscaffold-Enhanced Proton Therapy. (2013) (0)
126 POSTER Novel phage display-derived peptides for tumor- and vascular- targeted therapies against neuroblastoma (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wadih Arap?

Wadih Arap is affiliated with the following schools:

Wadih Arap's Academic­Influence.com Rankings

Wadih Arap's Degrees

Why Is Wadih Arap Influential?

Wadih Arap's Published Works

Published Works

What Schools Are Affiliated With Wadih Arap?

Wadih Arap's AcademicInfluence.com Rankings